PL4010351T3 - Estry montelukastu i zawierające je kompozycje farmaceutyczne - Google Patents

Estry montelukastu i zawierające je kompozycje farmaceutyczne

Info

Publication number
PL4010351T3
PL4010351T3 PL20746531.1T PL20746531T PL4010351T3 PL 4010351 T3 PL4010351 T3 PL 4010351T3 PL 20746531 T PL20746531 T PL 20746531T PL 4010351 T3 PL4010351 T3 PL 4010351T3
Authority
PL
Poland
Prior art keywords
montelukast
esters
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
PL20746531.1T
Other languages
English (en)
Inventor
Giuseppe Caliendo
Giuseppe Cirino
Ferdinando Fiorino
Francesco FRECENTESE
Marcelo Nicolás Muscará
Elisa PERISSUTTI
Antonio Petti
Vincenzo Santagada
Beatrice Severino
Fiorentina ROVIEZZO
Original Assignee
Genetic S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic S.P.A. filed Critical Genetic S.P.A.
Publication of PL4010351T3 publication Critical patent/PL4010351T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL20746531.1T 2019-08-06 2020-08-04 Estry montelukastu i zawierające je kompozycje farmaceutyczne PL4010351T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000014178A IT201900014178A1 (it) 2019-08-06 2019-08-06 Esteri del montelukast e loro formulazioni farmaceutiche
PCT/EP2020/071930 WO2021023751A1 (en) 2019-08-06 2020-08-04 Montelukast esters and pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
PL4010351T3 true PL4010351T3 (pl) 2024-03-11

Family

ID=68807309

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20746531.1T PL4010351T3 (pl) 2019-08-06 2020-08-04 Estry montelukastu i zawierające je kompozycje farmaceutyczne

Country Status (6)

Country Link
US (1) US12338266B2 (pl)
EP (1) EP4010351B1 (pl)
ES (1) ES2967138T3 (pl)
IT (1) IT201900014178A1 (pl)
PL (1) PL4010351T3 (pl)
WO (1) WO2021023751A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138232A2 (en) 2005-06-13 2006-12-28 Tvi Corporation Collapsible patient isolation pod
WO2006138212A1 (en) * 2005-06-14 2006-12-28 Gilead Sciences, Inc. SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
CA2663737A1 (en) 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
KR20100072295A (ko) * 2007-10-25 2010-06-30 머크 프로스트 캐나다 리미티드 병용 요법
WO2010126953A1 (en) * 2009-04-29 2010-11-04 Gilead Sciences, Inc. Corticosteroid linked beta-agonist compounds for use in therapy
WO2010132743A1 (en) * 2009-05-15 2010-11-18 Gilead Sciences, Inc. Corticosteroid beta-agonist compounds for use in therapy

Also Published As

Publication number Publication date
US20220251136A1 (en) 2022-08-11
IT201900014178A1 (it) 2021-02-06
EP4010351B1 (en) 2023-09-27
ES2967138T3 (es) 2024-04-26
US12338266B2 (en) 2025-06-24
EP4010351A1 (en) 2022-06-15
WO2021023751A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
IL263082B (en) New compounds as ototaxin inhibitors and pharmaceutical preparations containing them
IL289925B2 (en) A derivative of adenosine and a pharmaceutical preparation containing it
EP3706741A4 (en) PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL271807A (en) New compounds and their pharmaceutical preparations for the treatment of leprosy
PT3509638T (pt) Composições de ésteres de ácido canabidiólico e suas utilizações
EP3697411A4 (en) NEW PHARMACEUTICAL COMPOSITION AND ITS USE
EP3853204A4 (en) IMPROVED AND STABLE APREMILAST PHARMACEUTICAL COMPOSITIONS
IL287628B1 (en) Injectable pharmaceutical compounds and their uses
EP3960741A4 (en) QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND THEIR USES
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
HUE064916T2 (hu) Gyógyászati készítmény
EP3347022A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING DUTASTERIDE AND FORMULATION IN CAPSULE COMPRISING SAME
ZA202008034B (en) Ivosidenib forms and pharmaceutical compositions
EP4082579A4 (en) POLYNUCLEOTIDE AND MEDICINAL COMPOSITION
CA3277815A1 (en) Modified release pharmaceutical compositions of huperzine and methods of using the same
IL285728A (en) Pharmaceutical composition
IL276783A (en) The composition and pharmaceutical compound containing it
PL3949952T3 (pl) Kompozycja farmaceutyczna
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
PL4010351T3 (pl) Estry montelukastu i zawierające je kompozycje farmaceutyczne
EP3269709A4 (en) N-phenyl-n'-phenoxycarbonyl-phenylsulfonhydrazide derivative and pharmaceutical composition comprising same
PL4027974T3 (pl) Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę
GB201905509D0 (en) Pharmaceutical compositions and associated lits and uses
PL3980403T3 (pl) Sole montelukastu i zawierające je kompozycje farmaceutyczne
HUP1800273A2 (en) Stable pharmaceutical compositions and process for the preparation thereof